Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 20:04 UTC |
Ashworth AlanDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013069 · doc1.xml · derivative · entry 1 Ashworth Alan · CIK 0001886426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:04 UTC |
Jones Elaine VDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013070 · doc1.xml · derivative · entry 1 Jones Elaine V · CIK 0001296907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:05 UTC |
GLUCK FREDERICK WDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013071 · doc1.xml · derivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:06 UTC |
Meyers James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013073 · doc1.xml · derivative · entry 1 Meyers James R · CIK 0001387521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:07 UTC |
Young Matthew P.Director
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013075 · doc1.xml · derivative · entry 1 Young Matthew P. · CIK 0001601583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:07 UTC |
Mohindru ManiDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013074 · doc1.xml · derivative · entry 1 Mohindru Mani · CIK 0001664708 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:06 UTC |
Gilbert Halley EDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001567619-22-013072 · doc1.xml · derivative · entry 1 Gilbert Halley E · CIK 0001601360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:51 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,189 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001567619-22-010091 · doc1.xml · derivative · entry 5 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,189 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:51 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 66,742 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001567619-22-010091 · doc1.xml · derivative · entry 4 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,742 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:51 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 24,189 | $0.95 | $22,858.61 |
DisclosureSEC source: 0001567619-22-010091 · doc1.xml · nonDerivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 75,000 restricted stock units. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:51 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 66,742 | $0.95 | $63,071.19 |
DisclosureSEC source: 0001567619-22-010091 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 75,000 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:52 UTC |
ROWLAND LLOYD AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001567619-22-002524 · doc1.xml · derivative · entry 2 ROWLAND LLOYD A · CIK 0001236395 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-02-01 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:52 UTC |
ROWLAND LLOYD AGeneral Counsel
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002524 · doc1.xml · nonDerivative · entry 1 ROWLAND LLOYD A · CIK 0001236395 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,291 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. F2 · balance_after: Includes 22,500 RSUs. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:53 UTC |
Peterson Amy C.EVP, Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001567619-22-002525 · doc1.xml · derivative · entry 2 Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-01 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:53 UTC |
Peterson Amy C.EVP, Chief Development Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002525 · doc1.xml · nonDerivative · entry 1 Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,421 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. F2 · balance_after: Includes 40,000 RSUs. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:51 UTC |
HANNAH ALISON L.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001567619-22-002523 · doc1.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-02-01 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:51 UTC |
HANNAH ALISON L.Chief Medical Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002523 · doc1.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. F2 · balance_after: Includes 22,500 RSUs. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:50 UTC |
Campoy CarlosChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001567619-22-002522 · doc1.xml · derivative · entry 2 Campoy Carlos · CIK 0001761518 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-02-01 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:50 UTC |
Campoy CarlosChief Financial Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002522 · doc1.xml · nonDerivative · entry 1 Campoy Carlos · CIK 0001761518 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,921 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. F2 · balance_after: Includes 22,500 RSUs. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:49 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001567619-22-002521 · doc1.xml · derivative · entry 3 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2032-02-01 F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:49 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002521 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,922 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. F2 · balance_after: Includes 75,000 RSUs. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 16:29 UTC |
ROWLAND LLOYD AGeneral Counsel
|
GrantPerformance Stock Units (PSUs) · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-018719 · doc1.xml · derivative · entry 2 ROWLAND LLOYD A · CIK 0001236395 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 16:29 UTC |
ROWLAND LLOYD AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018719 · doc1.xml · derivative · entry 1 ROWLAND LLOYD A · CIK 0001236395 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:30 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantPerformance Stock Units (PSUs) · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-018720 · doc1.xml · derivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:30 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018720 · doc1.xml · derivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:26 UTC |
Peterson Amy C.EVP, Chief Development Officer
|
GrantPerformance Stock Units (PSUs) · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-018718 · doc1.xml · derivative · entry 2 Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:26 UTC |
Peterson Amy C.EVP, Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018718 · doc1.xml · derivative · entry 1 Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:25 UTC |
Campoy CarlosChief Financial Officer
|
GrantPerformance Stock Units (PSUs) · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-018717 · doc1.xml · derivative · entry 2 Campoy Carlos · CIK 0001761518 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:25 UTC |
Campoy CarlosChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018717 · doc1.xml · derivative · entry 1 Campoy Carlos · CIK 0001761518 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:24 UTC |
HANNAH ALISON L.Chief Medical Officer
|
GrantPerformance Stock Units (PSUs) · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-018716 · doc1.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date. Read SEC document |
| October 24, 2021 Filed Oct 26, 2021 20:24 UTC |
HANNAH ALISON L.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018716 · doc1.xml · derivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| September 29, 2021 Filed Oct 7, 2021 21:12 UTC |
Ashworth AlanDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001567619-21-018045 · doc1.xml · derivative · entry 1 Ashworth Alan · CIK 0001886426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-09-28 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 29, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 21:22 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 92,113 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001567619-21-015554 · doc1.xml · derivative · entry 3 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,113 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise of September 2021 expiring stock options with cash. F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 21:22 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 92,113 | $1.13 | $104,446.93 |
DisclosureSEC source: 0001567619-21-015554 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities held has been adjusted to reflect the transfer of 40 shares previously owned directly to Sean A. McCarthy 2018 Trust. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 22:44 UTC |
Jones Elaine VDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012367 · doc1.xml · derivative · entry 1 Jones Elaine V · CIK 0001296907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 18:46 UTC |
SCARLETT JOHN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012369 · doc1.xml · derivative · entry 1 SCARLETT JOHN A · CIK 0001270928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 18:43 UTC |
GLUCK FREDERICK WDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012365 · doc1.xml · derivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 22:45 UTC |
Meyers James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012368 · doc1.xml · derivative · entry 1 Meyers James R · CIK 0001387521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 22:48 UTC |
Mohindru ManiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012372 · doc1.xml · derivative · entry 1 Mohindru Mani · CIK 0001664708 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 22:47 UTC |
Young Matthew P.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012371 · doc1.xml · derivative · entry 1 Young Matthew P. · CIK 0001601583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 22:43 UTC |
Gilbert Halley EDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012364 · doc1.xml · derivative · entry 1 Gilbert Halley E · CIK 0001601360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 19:51 UTC |
McCarthy Sean A.Director · President and CEO
|
SaleCommon Stock | 100,000 | $7.04 | $704,470.00 |
DisclosureSEC source: 0001567619-21-012419 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 93,118 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · ownership.nature: Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:49 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001567619-21-012252 · doc1.xml · derivative · entry 5 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,742 Underlying: Common Stock · 10 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:49 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001567619-21-012252 · doc1.xml · derivative · entry 4 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,113 Underlying: Common Stock · 30 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:49 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 10 | $0.95 | $9.45 |
DisclosureSEC source: 0001567619-21-012252 · doc1.xml · nonDerivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:49 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 30 | $1.13 | $34.02 |
DisclosureSEC source: 0001567619-21-012252 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2021 Filed Jun 8, 2021 17:08 UTC |
Campoy CarlosChief Financial Officer
|
GrantCommon Stock | 3,320 | $6.09 | $20,205.52 |
DisclosureSEC source: 0001567619-21-011807 · doc1.xml · nonDerivative · entry 1 Campoy Carlos · CIK 0001761518 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421 F1 · kind: 3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 31, 2021 Filed Jun 8, 2021 17:07 UTC |
Peterson Amy C.EVP, Chief Development Officer
|
GrantCommon Stock | 3,320 | $6.09 | $20,205.52 |
DisclosureSEC source: 0001567619-21-011806 · doc1.xml · nonDerivative · entry 1 Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421 F1 · kind: 3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:37 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001567619-21-007541 · doc1.xml · derivative · entry 3 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,143 Underlying: Common Stock · 100,000 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:37 UTC |
McCarthy Sean A.Director · President and CEO
|
SaleCommon Stock | 100,000 | $7.49 | $749,470.00 |
DisclosureSEC source: 0001567619-21-007541 · doc1.xml · nonDerivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,894 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.35 to $7.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.